zacks.com / Page 4

AMP's third-quarter 2025 earnings beat is fueled by higher revenues and record AUM growth, offset partly by rising expenses.

CMG's third-quarter earnings beat forecasts, but revenues fall short, with shares plunging as weak traffic and margin pressures have clouded its outlook.

UDR posts higher Q3 FFOA and raises full-year guidance, fueled by rent growth and resilient same-store NOI performance.

Merck tops Q3 earnings and revenue estimates on strong oncology, new drugs and animal health sales, while narrowing its 2025 revenue outlook.

MELI's Q3 earnings miss estimates despite 39.5% revenue growth, fueled by strong commerce and fintech momentum.

BHRG powers Berkshire's insurance strength and investment returns, driving growth, profitability and capital efficiency across its vast portfolio.

EME posts higher third-quarter 2025 revenues and earnings year over year despite missing estimates, with record RPOs driving a 2.4% stock gain.

PWR delivers strong third-quarter results with double-digit growth, record backlog and a raised 2025 outlook driven by Electric segment momentum.

Amid earnings buzz, stocks like RadNet, Mission Produce, Castle Biosciences and FreightCar America stand out for their rising cash flows and resilience.

JetBlue posts a third-quarter loss as lower fuel costs cushion declining revenues, with it eyeing controlled capacity and higher expenses ahead.